04 Jun 2026 FibroBiologics Announces First Patients Dosed in Phase 1/2 Trial for Diabetic Foot Ulcers First-in-human trial of CYWC628 for diabetic foot ulcers begins — could fibroblast therapy heal the unhealable? Share Dan Smith This post is for subscribers only Subscribe now Already have an account? Sign in